Ternary solid dispersions: classification and formulation considerations S Borde, SK Paul, H Chauhan Drug Development and Industrial Pharmacy 47 (7), 1011-1028, 2021 | 21 | 2021 |
Formulation and characterization of ternary amorphous solid dispersions of a highly potent anti-tubercular agent and curcumin S Borde, P Hegde, P Prathipati, J North, D Kumari, H Chauhan Journal of Drug Delivery Science and Technology 64, 102564, 2021 | 10 | 2021 |
Investigating crystallization tendency, miscibility, and molecular interactions of drug–polymer systems for the development of amorphous solid dispersions F Meng, SK Paul, S Borde, H Chauhan Drug Development and Industrial Pharmacy 47 (4), 579-608, 2021 | 4 | 2021 |
Metabolic adaptation of NK cell activity and behavior in tumors: challenges and therapeutic opportunities S Borde, S Matosevic Trends in Pharmacological Sciences, 2023 | 3 | 2023 |
synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy KB Lupo, X Yao, S Borde, J Wang, S Torregrosa-Allen, BD Elzey, ... Nature Communications 15 (1), 1909, 2024 | | 2024 |
1206 Immunometabolic modulation of engineered iPSC-NK cells for immunotherapy of solid tumors S Borde, S Matosevic Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
Liquid ready-to-use formulation of levothyroxine PS Akasapu, R Kalhapure, MV Shah, S Borde, V Subramanian, ... US Patent 11,400,068, 2022 | | 2022 |
Solid Dosage Forms: Formulation and Characterization S Borde, D Singh, N Sharma, D Kumari, H Chauhan Handbook of Space Pharmaceuticals, 81-95, 2022 | | 2022 |
Development of Amorphous Ternary Solid Dispersions of a Novel Anti-Tubercular Indole-2-Carboxamide Derivative with Curcumin/Clofazimine for Tuberculosis Treatment S Borde Creighton University, 2019 | | 2019 |